Case Studies

Case Studies

Pan-cancer gene markers screening for variations

Genomics based testing of specific chromosomal loci associated to many diseases including cancer has been in practice for decades. With advancement in high throughput DNA sequencing, it is now possible to sequence hundreds of such loci at low cost and low turnaround time. “At Theomics, we have tested and validated a pan cancer multi loci susceptibility panel which in combination with Illumina MiSEQ deep sequencing platform will be able to accurately predict parameters like progressive rate, survival rate, and probable treatment recommendations. We believe this test could be of significant importance in treatment planning for many cancers as mortality rate of cancer patients are high due to treatment outcome rather than cancer aggression. We are expecting the cost for screening one patient / one sample to be as low as $89.

More Case Studies

Monitoring and Surveillance of Antimicrobial Resistance

Nobel laureate Joshua Lederberg wrote, “The future of humanity and microbes will likely evolve as … episodes of our wits vs their genes”. According to the latest report from WHO (World Health Organization) Antimicrobial resistance

COVID-19 Genome Sequencing Services

More than 1.2 million coronavirus genome sequences from 172 countries and territories have now been made available to accelerate research related to prediction of future pandemic, vaccine development and antiviral drug

Quantitative and Qualitative Identification and Reporting of existing and emerging livestock and Aquaculture pathogens

It is well known fact that billions of revenue loss occurs year on year due to outbreak of various pathogens that affect livestock and aquaculture.